Advocacy

Considering how the current emphasis on COVID-19 will affect your advocacy partners in other areas? We can help.

RESOURCES

A case for communicating uncertainty

We all want clear messaging on preventing the spread of COVID-19, whether it relates to vaccines, face masks, social distancing or any other guidance. That reflects our mantra within the healthcare communications industry: provide clear, concise and consistent messages that audiences understand. But science, by its nature, is associated with a level of uncertainty. And […]

View

We finally have a vaccine, but will this bring about a return to normality?

With unprecedented speed, the UK has become the first country to approve emergency use authorization for a COVID-19 vaccine that has been tested in a large-scale clinical trial.1 While this is a welcome milestone, it is important to remember that, as the vaccine is rolled out to millions of people, scientists and the public still […]

View

Understanding people’s fears and concerns relating to COVID-19 vaccines

Nowadays it is common practice to dismiss and even condemn people when their beliefs do not align with ours. When news began to circulate that ‘up to a third of people’ in the UK may refuse a coronavirus vaccine, based on a YouGov report of 1,663 adults, it was easy to blame this on anti-vaxxers. […]

View

Taking steps to ensure flu vaccinations are a priority in a pandemic

Every flu season is unpredictable. And while flu activity in the 2020–2021 season appears to be low so far, there may be a rise in influenza cases in the coming months at the same time the US is seeing an unprecedented number of COVID-19 cases. With emergency rooms and hospitals strained to capacity due to […]

View

Is the world ready for a COVID-19 vaccine?

At the beginning of the coronavirus pandemic, Dr Tedros Adhanom Ghebreyesus, Director General of the World Health Organization (WHO), dramatically told a G20 Leaders’ Summit that “we are at war with a virus that threatens to tear us apart.” At the same meeting, António Guterres, UN General Secretary, said “we are at war with a […]

View

Constructing a healthy digital world

Remember when global singer-songwriter Ed Sheeran announced he was quitting social media? He bade farewell to his 16 million Twitter followers, dumped his phone and spent months jetting around the world. That decision, five years ago, was perceived as unusual and even foolish. Quickly though, as if permission had been granted, going tech-free became on-trend. […]

View

Increasing access to mental health support

Our mental health has taken a beating this year. One of many ripple effects from COVID-19 is the toll that living through a pandemic has taken on people’s emotional, psychological and social wellbeing. Whether it’s stress from the blurring boundaries between work and home life, a sense of longing from not being able to see […]

View

Employee wellness tips for healthcare workers

The spread of COVID-19 has affected every industry, every facet of life. But its impact on healthcare providers is significantly higher than most and continues to create a ripple effect of significant burdens. Not only are healthcare workers experiencing grave challenges at work, but their concerns and worries extend home to their family members. Heathcare […]

View

Bridging gaps and building bridges to navigate healthcare avoidance

The current paradigm to strive to diagnose and treat diseases early and effectively remains unquestionable. However, COVID-19 has challenged this central dogma and left us with an unparalleled growing global healthcare crisis. Reports are clear that the pandemic is creating numerous ripple effects for patients who are facing delays to both the diagnosis and treatment […]

View

COVID-19 is threatening the progress of clinical trials

The financial impact of the COVID-19 pandemic presents a potential risk to the future of clinical trials in rare diseases. Rare diseases by their nature are not very prevalent in the population, therefore, any treatment for a rare disease will only have a small number of beneficiaries. In addition, so-called orphan drug development takes around 18% […]

View

Assessing and managing issues around clinical trials: a multi-stakeholder approach

Many companies are facing challenging decisions on whether to proceed with clinical trials in the coming months as countries experience varying degrees of lockdown.

View

Patient advocates: hard hit at the time of greatest need

With reduced capacity and opportunity for fundraising, extra pressure on support services and attention diverted elsewhere, it will take a long time for them to recover and return to business as usual.

View

Unlocking virtual medical congresses

Medical congresses – crucial for the presentation of trial data, scientific exchange and the opportunity to engage with medical professionals, patient advocates, media and analysts – have been cancelled, postponed or are moving to virtual/part virtual.

View

No two virtual congresses are the same

Each congress has a different structure to its overall program and method in delivering its scientific information, despite stating that they all plan to keep to the traditional congress format.

Download PDF

Get in Touch

We know there are numerous considerations when it comes to the impact of COVID-19 and what this means for your organization. We are here to help.